,date,information,related
0,2022-09-23,"Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.49% to $334.20 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
1,2022-10-02,"Headline: Tracking Ron Baron's BAMCO Portfolio - Q2 2022 Update, source:SeekingAlpha, summary: Ron Baron's 13F portfolio value decreased from $40.75B to $31.14B this quarter. Click here to read more about BAMCO's holdings and trades for Q2 2022.",IDXX
2,2022-10-04,"Headline: Don't Miss the Turnaround in These 3 Stocks, source:InvestorPlace, summary: Of the 48 companies down more than double the S&P 500 year-to-date, these are the three stocks to buy for a turnaround in 2023., Headline: Don’t Miss the Turnaround in These 3 Stocks, source:Yahoo, summary: I’m on the hunt for stocks to buy that are primed for a turnaround in the final quarter of 2022 and into 2023. But what constitutes a turnaround? The S&P 500 is down more than 23% year-to-date through Oct. 3. Is that the place to start? Or do we look for an even more significant recovery? According to Finviz.com, there are currently 48 companies with a YTD return of -46% (double the index) or worse through the first nine months of 2022. I’ll find the three stocks to buy whose turnarounds you don",IDXX
3,2022-10-11,"Headline: Is Now An Opportune Moment To Examine IDEXX Laboratories, Inc. (NASDAQ:IDXX)?, source:Yahoo, summary: Today we're going to take a look at the well-established IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's stock..., Headline: IDEXX Laboratories to Release 2022 Third Quarter Financial Results, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 third quarter results for Tuesday, November 1, 2022 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.",IDXX
4,2022-10-13,"Headline: Elanco: Great Potential - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by Praveen Chawla and the topic is about: Elanco is the second-largest company in animal health pharmaceuticals.  It is under-earning and undervalued., Headline: IDEXX Laboratories Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.16% to $335.22 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
5,2022-10-14,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 3.16% to $324.64 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",IDXX
6,2022-10-17,"Headline: IDEXX Laboratories Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 4.57% to $339.49 Monday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
7,2022-10-18,"Headline: IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.79% higher to $342.16 Tuesday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
8,2022-10-19,"Headline: IDEXX (IDXX) to Report Q3 Earnings: What's in the Cards?, source:Yahoo, summary: IDEXX's (IDXX) CAG premium instrument placements are expected to have recorded significant growth in Q3 on the continued rise in Catalyst and premium hematology placements.",IDXX
9,2022-10-20,"Headline: IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 1.28% to $331.20 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
10,2022-10-21,"Headline: IDEXX Laboratories Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.95% to $337.65 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
11,2022-10-23,"Headline: Baxter International: Despite Weakening On The Bottom Line, Shares Look Attractive, source:SeekingAlpha, summary: Baxter International has had a rough year or so, with shares declining far more than the market has. See why I'm changing my rating on BAX from Hold to a Buy.",IDXX
12,2022-10-24,"Headline: Optimizing Portfolio Construction With Bayesian Analysis, source:SeekingAlpha, summary: With the aid of powerful statistical methods, portfolios can be constructed that produce market-beating returns while minimizing the probability of loss.",IDXX
13,2022-10-25,"Headline: Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?, source:Yahoo, summary: Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",IDXX
14,2022-10-26,"Headline: A Quality Checkup On IDEXX Laboratories, source:SeekingAlpha, summary: IDEXX Laboratories is operating in an industry with good tailwinds. Over the last decade, the company returned 22% annually. See why I rate IDXX stock a hold., Headline: FIW: Water Is Expensive, source:SeekingAlpha, summary: FIW holds 36 companies that derive a substantial portion of revenues from potable and wastewater industry. See why I don't recommend investors buy FIW today., Headline: Nevro (NVRO) Expected to Beat Earnings Estimates: Should You Buy?, source:Yahoo, summary: Nevro (NVRO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.69% to $358.30 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
15,2022-10-27,"Headline: IDEXX Laboratories Inc. stock falls Thursday, still outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.60% to $356.14 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",IDXX
16,2022-10-28,"Headline: Global company events calendar - next 7 days, source:Alliance News, summary: No summary, Headline: IDEXX Laboratories Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.29% to $364.28 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
17,2022-10-31,"Headline: MedTech Stocks Due to Report Earnings on Nov 1: MCK, CTLT & More, source:Yahoo, summary: MedTech companies' Q3 results are likely to reflect strength in customer demand. Let's see how MCK, CTLT, ECL, ABMD, HSIC and IDXX are placed ahead of their earnings releases., Headline: IDEXX Laboratories Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.26% to $359.68 Monday, on what proved to be an all-around dismal trading session for the stock market, with the..., Headline: Stocks making the biggest moves after hours: Avis, Stryker and more, source:CNBC, summary: These are the stocks posting the largest moves after the bell. , Headline: GLOBAL BRIEFING: China manufacturing continues to contract in October, source:Alliance News, summary: No summary",IDXX
18,2022-11-01,"Headline: Idexx Laboratories reports Q3 comparable EPS $2.23, consensus $2.04, source:Thefly.com, summary: Reports Q3 revenue $841.6... IDXX, Headline: Idexx Laboratories cuts FY22 EPS view to $7.74-$7.98 from $8.11-$8.35, source:Thefly.com, summary: Consensus $7.95. Sees FY2... IDXX, Headline: Idexx: Q3 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: IDEXX Laboratories 3Q Profit, Revenue Rise on Companion Animal Group Diagnostics Unit, source:MarketWatch, summary: By Sabela Ojea IDEXX Laboratories Inc. on Tuesday posted a rise in profit for the third quarter, with sales increasing on the back of the company's companion..., Headline: Early notable gainers among liquid option names on November 1st, source:Thefly.com, summary: No summary, Headline: BOURNE LENT ASSET MANAGEMENT INC`s Top 5 Sells of the 3rd Quarter, source:GuruFocus, summary: No summary, Headline: BOURNE LENT ASSET MANAGEMENT I - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: , Headline: IDEXX Laboratories, Inc. 2022 Q3 - Results - Earnings Call Presentation, source:SeekingAlpha, summary: The following slide deck was published by IDEXX Laboratories, Inc., Headline: IDEXX Laboratories rises on Q3 beat, narrows FY22 outlook on forex impact, source:Seeking Alpha, summary: No summary, Headline: IDEXX Laboratories Announces Third Quarter Results, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results and an update on U.S. companion animal diagnostics trends., Headline: IDEXX Laboratories Stock Climbs 10% as It Beats 3Q Market Views, source:MarketWatch, summary: By Sabela Ojea Shares of IDEXX Laboratories Inc. rose more than 10% Tuesday after the veterinary diagnostics company posted higher-than-expected increases in..., Headline: Idexx Laboratories (IDXX) Beats Q3 Earnings and Revenue Estimates, source:Yahoo, summary: Idexx (IDXX) delivered earnings and revenue surprises of 5.39% and 1.50%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?, Headline: IDEXX Laboratories, Inc. (IDXX) Q3 2022 Earnings Call Transcript, source:SeekingAlpha, summary: IDEXX Laboratories, Inc. (NASDAQ:NASDAQ:IDXX) Q3 2022 Earnings Conference Call November 1, 2022, 08:30 AM ET Company Participants Brian McKeon - CFO Jay Mazelsky - CEO Conference Call..., Headline: Stocks making the biggest moves midday: Uber, Abiomed, Peloton, Carvana, Molson Coors and more, source:CNBC, summary: These are the stocks posting the largest moves in midday trading Tuesday, Nov. 1., Headline: IDEXX income rises as revenue grows thanks to companion animal group, source:Alliance News, summary: No summary, Headline: Why IDEXX Stock Popped Today, source:Yahoo, summary: Shares of IDEXX Laboratories (NASDAQ: IDXX) were moving higher today after the veterinary healthcare company posted better-than-expected results in its third-quarter earnings but slashed its full-year earnings guidance due to the stronger dollar and higher interest rates.  The company said overall revenue was up 4% in the quarter to $841.7 million, but organic sales, which adjust for currency headwinds, increased 8%.  Organic revenue in U.S. pet diagnostics, its biggest business segment, was up 10%, and the company saw 14% growth in its global premium installed instrument base, which bodes well for future sales., Headline: IDEXX (IDXX) Q3 Earnings Beat Estimates, 2022 EPS View Down, source:Yahoo, summary: IDEXX's (IDXX) Q3 top-line performance rides on strong CAG Diagnostics recurring revenue growth., Headline: NEW YORK MARKET CLOSE: New York defies bullish mood on pre-Fed nerves, source:Alliance News, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 9.80% to $394.93 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the..., Headline: Top 10 Gainers Today, source:Yahoo, summary: In this article, we will take a look at the top 10 gainers today. If you want to see some other stocks moving higher on Tuesday, go directly to Top 5 Gainers Today. All three major U.S. indices turned red in mid-day trading Tuesday after the Bureau of Labor Statistics released better-than-expected job openings data […]",IDXX
19,2022-11-02,"Headline: Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), Idexx Laboratories (IDXX) and Waters (WAT), source:TipRanks, summary: No summary, Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 5.64% to $372.64 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the...",IDXX
20,2022-11-03,"Headline: IDEXX Laboratories Inc. stock falls Thursday, still outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. dropped 0.93% to $369.19 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...",IDXX
21,2022-11-04,"Headline: IDEXX Laboratories Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.70% higher to $371.79 Friday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
22,2022-11-06,"Headline: Top 5 3rd Quarter Trades of Biondo Investment Advisors, LLC, source:GuruFocus, summary: No summary, Headline: Top 5 3rd Quarter Trades of Bi - GuruFocus.com, source:GuruFocus, summary: GuruFocus Article or News written by insider and the topic is about: ",IDXX
23,2022-11-07,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 3.61% to $385.20 Monday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
24,2022-11-08,"Headline: IDEXX Laboratories Third Quarter 2022 Earnings: Beats Expectations, source:Yahoo, summary: IDEXX Laboratories ( NASDAQ:IDXX ) Third Quarter 2022 Results Key Financial Results Revenue: US$841.7m (up 3.9% from 3Q..., Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 0.60% to $382.90 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
25,2022-11-09,"Headline: IDEXX Laboratories Inc. stock falls Wednesday, still outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. dropped 0.79% to $379.88 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with..., Headline: IDXX Crosses Above Key Moving Average Level, source:Market News Video, summary: No summary",IDXX
26,2022-11-11,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 6.06% to $441.27 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
27,2022-11-12,"Headline: Baron Funds Q3 2022 Report - Letter From Ron, source:Seeking Alpha, summary: No summary",IDXX
28,2022-11-14,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 3.00% to $428.03 Monday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
29,2022-11-15,"Headline: Analysts Offer Insights on Healthcare Companies: Biogen (BIIB), Idexx Laboratories (IDXX) and Arcutis Biotherapeutics (ARQT), source:TipRanks, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.48% to $434.38 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the..., Headline: ACADEMY CAPITAL MANAGEMENT INC/TX Buys 2, Sells 3 in 3rd Quarter, source:GuruFocus, summary: No summary",IDXX
30,2022-11-16,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.91% to $426.08 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",IDXX
31,2022-11-17,"Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 3.67% to $410.44 Thursday, on what proved to be an all-around poor trading session for the stock market, with the...",IDXX
32,2022-11-18,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.84% higher to $413.89 Friday, on what proved to be an all-around favorable trading session for the stock market,...",IDXX
33,2022-11-20,"Headline: IDEXX Laboratories Inc. stock falls Monday, still outperforms market, source:MarketWatch, summary: No summary",IDXX
34,2022-11-21,"Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
35,2022-11-23,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors despite daily gains, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.07% to $416.53 Wednesday, on what proved to be an all-around great trading session for the stock market, with...",IDXX
36,2022-11-25,"Headline: U.S. avian flu outbreak worst in history, source:Seeking Alpha, summary: No summary",IDXX
37,2022-11-28,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 2.74% to $400.10 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
38,2022-11-29,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.21% to $408.96 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",IDXX
39,2022-12-01,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 3.12% to $439.17 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
40,2022-12-02,"Headline: Avanos Medical (AVNS) Up 21% Since Last Earnings Report: Can It Continue?, source:Yahoo, summary: Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slumped 0.88% to $435.30 Friday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
41,2022-12-05,"Headline: IDEXX Laboratories: Not Enough Visibility, Hold, source:SeekingAlpha, summary: IDEXX Laboratories outperformed the S&P 500 since my initial article. See why I consider IDXX as an outstanding business but yet on a wait-and-see mode., Headline: IDEXX Laboratories Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 2.99% to $422.30 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P..., Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
42,2022-12-07,"Headline: 11 Best Pet Stocks To Buy Now, source:Yahoo, summary: In this article, we discuss 11 best pet stocks to buy now. If you want to see more stocks in this selection, check out 5 Best Pet Stocks To Buy Now. Morgan Stanley expects annual growth of 8% in the pet industry by 2030, noting that there has been an addition of nearly 5 million […]",IDXX
43,2022-12-08,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.01% to $428.54 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",IDXX
44,2022-12-09,"Headline: IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.85% to $420.63 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
45,2022-12-12,"Headline: IDEXX Laboratories (NASDAQ:IDXX) shareholders have earned a 22% CAGR over the last five years, source:Yahoo, summary: The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put..., Headline: IDEXX Laboratories Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.59% higher to $423.11 Monday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
46,2022-12-13,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.89% to $435.35 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P..., Headline: The 7 Best Stocks to Buy for 2023, source:InvestorPlace, summary: No summary",IDXX
47,2022-12-14,"Headline: IDEXX (IDXX) CAG Sales Growth Strong, Costs Continue to Rise, source:Yahoo, summary: IDEXX's (IDXX) international revenues are primarily aided by gains in CAG and Water businesses., Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.22% to $430.03 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
48,2022-12-15,"Headline: Here's Why You Should Invest in IDEXX (IDXX) Stock for Now, source:Yahoo, summary: Investors are optimistic about IDEXX (IDXX) owing to strong international growth., Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 3.41% to $415.38 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
49,2022-12-16,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 1.85% to $407.71 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
50,2022-12-18,"Headline: Idexx Laboratories (IDXX) Shares Cross Below 200 DMA, source:Market News Video, summary: No summary",IDXX
51,2022-12-19,"Headline: IDEXX Laboratories Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.36% to $402.17 Monday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
52,2022-12-21,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 3.04% to $418.06 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
53,2022-12-22,"Headline: IDEXX Laboratories Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.22% to $412.96 Thursday, on what proved to be an all-around grim trading session for the stock market, with the..., Headline: IDEXX Laboratories to Present at the Goldman Sachs Healthcare CEOs Unscripted Conference, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Goldman Sachs Healthcare CEOs Unscripted Conference on Thursday, January 5, 2023. Jay Mazelsky, President and Chief Executive Officer will participate in a fireside chat at 1:15 pm ET.",IDXX
54,2022-12-23,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slumped 0.58% to $410.58 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
55,2022-12-26,"Headline: 3 Surefire Stocks I'm Buying for My Daughter's Portfolio in 2023, source:Yahoo, summary: By focusing on her interests, I hope to show my daughter that fascinating businesses are all around her.",IDXX
56,2022-12-27,"Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.41% to $404.80 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
57,2022-12-28,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 1.20% to $399.93 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
58,2022-12-29,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 2.61% to $410.38 Thursday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
59,2022-12-30,"Headline: IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. dropped 0.59% to $407.96 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",IDXX
60,2022-12-31,"Headline: Tracking Terry Smith`s Fundsmith 13F Portfolio - Q3 2022 Update, source:Seeking Alpha, summary: No summary, Headline: Tracking Terry Smith's Fundsmith 13F Portfolio - Q3 2022 Update, source:SeekingAlpha, summary: Fundsmithâs 13F portfolio value decreased from $23.45B to $21.07B this quarter. Click here to read an update on the portfolio.",IDXX
61,2023-01-03,"Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.48% to $406.01 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",IDXX
62,2023-01-04,"Headline: Is It Time To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?, source:Yahoo, summary: Let's talk about the popular IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's shares led the NASDAQGS gainers..., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 4.04% to $422.43 Wednesday, on what proved to be an all-around positive trading session for the stock market, with..., Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
63,2023-01-06,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 6.82% to $447.77 Friday, on what proved to be an all-around favorable trading session for the stock market, with the...",IDXX
64,2023-01-08,"Headline: IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders made a handsome profit after selling stock presently valued at US$448 apiece for US$510, source:Yahoo, summary: Even though IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) stock gained 9.8% last week, insiders who sold US$127k worth of...",IDXX
65,2023-01-09,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.07% higher to $448.08 Monday, on what proved to be an all-around grim trading session for the stock market, with..., Headline: IDEXX Laboratories Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating, source:Yahoo, summary: The Relative Strength (RS) Rating for IDEXX Laboratories stock entered a new percentile Monday, with a rise from 67 to 84.  When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.  IBD's unique RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that shows how a stock's price performance over the last 52 weeks matches up against the rest of the market.",IDXX
66,2023-01-10,"Headline: IDEXX Laboratories Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 4.69% to $469.11 Tuesday, on what proved to be an all-around positive trading session for the stock market, with..., Headline: Fundsmith Equity Fund 2022 Annual Letter To Shareholders, source:Seeking Alpha, summary: No summary, Headline: Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter, source:GuruFocus, summary: No summary",IDXX
67,2023-01-11,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.30% to $463.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
68,2023-01-12,"Headline: VolitionRx:  Nu.Q Vet Cancer Test available through Idexx Laboratories network, source:Thefly.com, summary: No summary, Headline: Does IDEXX Laboratories (NASDAQ:IDXX) Have A Healthy Balance Sheet?, source:Yahoo, summary: The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says..., Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.44% to $469.71 Thursday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
69,2023-01-13,"Headline: 5 Stocks Powering Nasdaq ETF to Start 2023, source:Yahoo, summary: The rally has been broad-based. And the high beta and high growth sector took charge, with the tech-heavy Nasdaq Composite Index rising 5.1% in the initial two weeks of 2023., Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.99% to $479.08 Friday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
70,2023-01-17,"Headline: IDEXX (IDXX) Aided by Global Growth, Solid Instrument Placement, source:Yahoo, summary: IDEXX's (IDXX) rapid assay revenue growth is supported by solid volume gains in the United States and benefits from net price increases., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.23% higher to $480.19 Tuesday, on what proved to be an all-around grim trading session for the stock market, with..., Headline: Why Idexx (IDXX) Could Beat Earnings Estimates Again, source:Yahoo, summary: Idexx (IDXX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",IDXX
71,2023-01-18,"Headline: Here's How Much You'd Have If You Invested $1000 in Idexx Laboratories a Decade Ago, source:Yahoo, summary: Holding on to popular or trending stocks for the long-term can make your portfolio a winner., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.24% higher to $481.32 Wednesday, on what proved to be an all-around grim trading session for the stock market,...",IDXX
72,2023-01-19,"Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 1.29% to $475.13 Thursday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
73,2023-01-22,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",IDXX
74,2023-01-23,"Headline: IDEXX (IDXX) to Report Q4 Earnings: What's in the Cards?, source:Yahoo, summary: IDEXX's (IDXX) CAG premium instrument placements are expected to have recorded significant growth in Q4 owing to continued rise in Catalyst and premium hematology placements., Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
75,2023-01-24,"Headline: First Week of March 17th Options Trading For Idexx Laboratories (IDXX), source:Stock Options Channel, summary: No summary, Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: No summary",IDXX
76,2023-01-25,"Headline: Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Idexx Laboratories (IDXX) and Johnson & Johnson (JNJ), source:TipRanks, summary: No summary, Headline: Idexx Laboratories (IDXX) Earnings Expected to Grow: What to Know Ahead of Q4 Release, source:Yahoo, summary: Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: IDEXX Laboratories Is Barking Up the Right Tree, source:Yahoo, summary: In the daily bar chart of IDXX, below, I see a base pattern and an upside breakout and rally.  The On-Balance-Volume (OBV) line is showing strength in January after a long sideways move from May. The Moving Average Convergence Divergence (MACD) oscillator is above the zero line but shows some narrowing that needs to be monitored.  The weekly OBV line has been improving since October., Headline: IDEXX Laboratories Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: No summary",IDXX
77,2023-01-26,"Headline: IDEXX Laboratories to Release 2022 Fourth Quarter and Full Year Financial Results, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 fourth quarter and full year financial results for Monday, February 6, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day., Headline: IDEXX Laboratories Inc. stock remains steady Friday, underperforms market, source:MarketWatch, summary: No summary",IDXX
78,2023-01-30,"Headline: IDEXX Laboratories Inc. stock falls Monday, still outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slumped 0.83% to $482.95 Monday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
79,2023-01-31,"Headline: Top 5 Nasdaq Composite Stocks to Buy Ahead of Q4 Earnings, source:Yahoo, summary: Five Nasdaq Composite companies are set to beat earnings estimates. These are: EXPE, IDXX, SNY, TW and SEDG., Headline: SONVY or IDXX: Which Is the Better Value Stock Right Now?, source:Yahoo, summary: SONVY vs. IDXX: Which Stock Is the Better Value Option?, Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 0.51% to $480.50 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
80,2023-02-01,"Headline: The Zacks Analyst Blog Highlights Expedia, IDEXX Laboratories, Tradeweb Markets, SolarEdge Technologies and Sanofi, source:Yahoo, summary: Expedia, IDEXX Laboratories, Tradeweb Markets, SolarEdge Technologies and Sanofi are included in this Analyst Blog., Headline: IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.56% higher to $483.20 Wednesday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
81,2023-02-02,"Headline: Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline, source:Yahoo, summary: Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 4.35% to $504.22 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",IDXX
82,2023-02-03,"Headline: Here's How Much a $1000 Investment in Idexx Laboratories Made 10 Years Ago Would Be Worth Today, source:Yahoo, summary: Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more., Headline: NEW YORK MARKET CLOSE: Dollar firms after US jobs report, stocks fall, source:Alliance News, summary: No summary, Headline: IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 4.33% to $482.41 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
83,2023-02-04,"Headline: Is It Too Late To Consider Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?, source:Yahoo, summary: IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) led the NASDAQGS gainers with a relatively large price hike in the past couple...",IDXX
84,2023-02-05,"Headline: Five Best And Worst Performing Healthcare Stocks In January 2023, source:TalkMarkets, summary: No summary, Headline: GLOBAL BRIEFING: China relations with US ""damaged"" by balloon shooting, source:Alliance News, summary: No summary, Headline: Stocks slip as worries about high rates weigh on Wall Street, source:Associated Press, The, summary: No summary",IDXX
85,2023-02-06,"Headline: Idexx Laboratories reports Q4 comparable EPS $2.07, consensus $1.94, source:Thefly.com, summary: No summary, Headline: Idexx Laboratories sees FY23 comparable EPS up 19%-26%, consensus $9.50, source:Thefly.com, summary: No summary, Headline: IDEXX Laboratories Non-GAAP EPS of $2.07 beats by $0.15, revenue of $828.57M beats by $7.66M, initiates 2023 guidance, source:Seeking Alpha, summary: No summary, Headline: Idexx Posts Higher 4Q Revenue as Pet-Health Demand Holds up, source:MarketWatch, summary: By Will Feuer Idexx Laboratories Inc. posted higher fourth-quarter revenue as demand for the company's pet-diagnostics offerings held up. The Westbrook,..., Headline: Idexx: Q4 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: Idexx Forecasts 2023 Sales Growth on Resilient Pet-Health Demand, source:MarketWatch, summary: By Will Feuer Idexx Laboratories Inc. said it expects sales to continue growing this year on strong underlying U.S. pet trends. The Westbrook, Maine-based..., Headline: IDEXX Laboratories revenue rises thanks to companion animal group, source:Alliance News, summary: No summary, Headline: Fly Intel: Pre-market Movers, source:Thefly.com, summary: No summary, Headline: IDEXX Laboratories Announces Fourth Quarter and Full Year 2022 Results, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results, as well as an update on U.S. companion animal diagnostic trends., Headline: Idexx Laboratories (IDXX) Q4 Earnings and Revenues Beat Estimates, source:Yahoo, summary: Idexx (IDXX) delivered earnings and revenue surprises of 6.77% and 1.48%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?, Headline: IDEXX Laboratories, Inc. (IDXX) Q4 2022 Earnings Call Transcript, source:SeekingAlpha, summary: IDEXX Laboratories, Inc. (NASDAQ:NASDAQ:IDXX) Q4 2022 Results Conference Call February 6, 2023 8:30 AM ETCompany ParticipantsJay Mazelsky - President and Chief Executive OfficerBrian McKeon..., Headline: Analyst Says IDEXX Laboratories' Long-Term Growth Outlook Remains Strong, source:Yahoo, summary: IDEXX Laboratories Inc (NASDAQ: IDXX) reported Q4 FY22 sales of $829 million, up 3% Y/Y, beating the consensus of $820.91 million. Adjusted EPS was $2.07, beating the consensus. CAG Diagnostics recurring revenue gains of 4% reported and 8% organic in the quarter were supported by continued benefits from IDEXX execution drivers. CAG revenue gains also reflect veterinary software, services, and diagnostic imaging systems revenue growth of 15% as reported and 17% organically, supported by software, Headline: IDEXX (IDXX) Q4 Earnings Beat Estimates, Margins Increases, source:Yahoo, summary: IDEXX's (IDXX) Q4 revenues are driven by continued benefits from expanding the global premium instrument installed base., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",IDXX
86,2023-02-07,"Headline: Analysts Have Conflicting Sentiments on These Healthcare Companies: Idexx Laboratories (IDXX), Neurocrine (NBIX) and aTyr Pharma (LIFE), source:TipRanks, summary: No summary, Headline: Analysts Offer Insights on Healthcare Companies: Cigna (CI), Idexx Laboratories (IDXX) and Lyra Therapeutics (LYRA), source:TipRanks, summary: No summary, Headline: Analysts Are Bullish on Top Healthcare Stocks: Arrowhead Pharmaceuticals (ARWR), Cigna (CI), source:TipRanks, summary: No summary, Headline: Is AEterna Zentaris (AEZS) Stock Outpacing Its Medical Peers This Year?, source:Yahoo, summary: Here is how Aeterna Zentaris (AEZS) and Idexx Laboratories (IDXX) have performed compared to their sector so far this year., Headline: IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2022 Earnings Call Transcript, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2022 Earnings Call Transcript February 6, 2023 Operator: Good morning, and welcome to the IDEXX Laboratories Fourth Quarter 2022 Earnings Conference Call. As a reminder, today’s conference is being recorded. Participating in the call this morning are Jay Mazelsky, President and Chief Executive Officer; Brian McKeon, Chief Financial Officer; and […], Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: No summary, Headline: Idexx Laboratories price target raised to $590 from $582 at Barclays, source:Thefly.com, summary: No summary",IDXX
87,2023-02-08,"Headline: IDEXX Laboratories, Inc. (NASDAQ:IDXX) insiders made a handsome sum after selling stock worth US$508 per share at present for US$510, source:Yahoo, summary: Despite the fact that IDEXX Laboratories, Inc. (NASDAQ:IDXX) stock rose 5.1% last week, insiders who sold US$127k worth..., Headline: Why Investors Need to Take Advantage of These 2 Medical Stocks Now, source:Yahoo, summary: The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now., Headline: IDEXX Laboratories Q4 Earnings: Strong Margin Expansion But Too Expensive, source:SeekingAlpha, summary: IDEXX Laboratories' share price has increased over 55% since last October. See why I rate IDXX stock as a hold., Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary",IDXX
88,2023-02-09,"Headline: IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
89,2023-02-10,"Headline: 2 Top Stocks I'm Buying Hand Over Fist in February, source:Yahoo, summary: While earnings reports are a great way to monitor a stock's financial progress, checking in on a company's longer-term investment thesis is far more critical.  Two examples where it would be wise to keep this theory in mind are Pinterest (NYSE: PINS) and Idexx Laboratories (NASDAQ: IDXX).  With that said, here's why I'm excited to add to Pinterest and Idexx Labs here in February.",IDXX
90,2023-02-12,"Headline: IDEXX Laboratories' (NASDAQ:IDXX) investors will be pleased with their strong 166% return over the last five years, source:Yahoo, summary: When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...",IDXX
91,2023-02-13,"Headline: Is IDEXX Laboratories (IDXX) a High-Growth Stock?, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund increased by 12.21% in the fourth quarter, outperforming the Russell Midcap Growth Index which returned 6.90%. Stock selection and underexposure to stocks with high measures of Residual Volatility and […], Headline: 2 Top Healthcare Stocks to Buy Right Now, source:Yahoo, summary: Geron Corporation (NASDAQ: GERN) and Idexx Laboratories (NASDAQ: IDXX) are both poised to grow and make great long-term healthcare investments, but for different reasons.  Geron, a clinical-stage biopharmaceutical company, is about to bring its first product to market, and it has the potential to be a blockbuster with applications in blood oncology and beyond.  Idexx is more established and has grown revenue steadily., Headline: IDEXX Laboratories Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 2.25% to $496.68 Monday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
92,2023-02-14,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.40% to $503.65 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the...",IDXX
93,2023-02-15,"Headline: IDEXX Laboratories Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 2.17% to $514.59 Wednesday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
94,2023-02-16,"Headline: We Think IDEXX Laboratories (NASDAQ:IDXX) Can Stay On Top Of Its Debt, source:Yahoo, summary: David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the..., Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 1.59% to $506.40 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
95,2023-02-17,"Headline: Ron Baron Comments on IDEXX Laboratories, source:GuruFocus, summary: No summary, Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.96% to $496.46 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",IDXX
96,2023-02-20,"Headline: Groundbreaking IDEXX Study Reveals Opportunities to Increase Veterinary Practice Productivity, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced a first-of-its-kind empirical study aimed at addressing veterinary practice capacity constraints. In the publication Finding the Time: Empowering Veterinary Teams to Get the Most Out of Every Day, IDEXX introduces the veterinary Practice Productivity Index™, a data-driven framework and collection of guides for transforming practice productivity across the dimensions of workflow, technology, and, Headline: TMO vs. IDXX: Which Stock Is the Better Value Option?, source:Yahoo, summary: TMO vs. IDXX: Which Stock Is the Better Value Option?",IDXX
97,2023-02-21,"Headline: Elanco drives animal health stocks lower as 2023 guidance disappoints, source:Seeking Alpha, summary: No summary, Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 3.68% to $478.17 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P..., Headline: IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in two upcoming conferences:",IDXX
98,2023-02-22,"Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.39% to $476.29 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
99,2023-02-23,"Headline: Are Medical Stocks Lagging  IDEXX Laboratories (IDXX) This Year?, source:Yahoo, summary: Here is how Idexx Laboratories (IDXX) and Aeterna Zentaris (AEZS) have performed compared to their sector so far this year., Headline: 3 Medical Instruments Stocks to Buy Amid Improving Industry Trends, source:Yahoo, summary: The Zacks Medical - Instruments industry is growing on rising demand for digital health. EW, IDXX and HOLX are set to gain the most. Yet, the ongoing inflation, in the form of rising freight, raw material costs, is disrupting the trend., Headline: IDEXX Laboratories Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.43% higher to $478.35 Thursday, on what proved to be an all-around favorable trading session for the stock market,...",IDXX
100,2023-02-24,"Headline: Zacks Industry Outlook Highlights Edwards Lifesciences, IDEXX Laboratories and Hologic, source:Yahoo, summary: Edwards Lifesciences, IDEXX Laboratories and Hologic have been highlighted in this Industry Outlook article., Headline: IDEXX Laboratories: Excellent Business But Extremely Overpriced, source:SeekingAlpha, summary: IDEXX Laboratories delivered solid and consistent results that rival the Googles, Metas, and Microsofts out there. Click here for more on IDXX., Headline: IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 2.13% to $468.17 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P..., Headline: Baron Asset Fund Q4 2022 Quarterly Letter, source:SeekingAlpha, summary: Baron Asset Fund increased 12.21% during the fourth quarter of 2022, outperforming the Russell Midcap Growth Index. Click here to read the full fund letter.",IDXX
101,2023-02-27,"Headline: VNRX: Nu.Q Vet Cancer Test Being Launched by Supply Agreement Partners Heska and IDEXX; 4.945 million Share Offering Completed to Help Fund Management’s Initiatives, source:Yahoo, summary: By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT VolitionRx (NYSE:VNRX) is a multi-national epigenetics company with a focus on developing diagnostic blood tests (assays) that can help detect a range of cancers and other diseases so that appropriate treatment may be prescribed. Blood tests are a diagnostic tool that is relatively simple to administer, convenient and, Headline: How to Find Strong Medical Stocks Slated for Positive Earnings Surprises, source:Yahoo, summary: Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates., Headline: IDEXX (IDXX) Global Sales, Instrument Placement Robust, source:Yahoo, summary: IDEXX (IDXX) continues to demonstrate solid growth globally, primarily aided by a gain in CAG and Water businesses., Headline: IDEXX Laboratories Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.00% higher to $468.18 Monday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
102,2023-02-28,"Headline: Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now, source:Yahoo, summary: Investors are optimistic about IDEXX's (IDXX) strong global performance.",IDXX
103,2023-03-01,"Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. dropped 0.87% to $469.10 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
104,2023-03-02,"Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.50% to $476.13 Thursday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
105,2023-03-03,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 2.49% to $488.00 Friday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
106,2023-03-06,"Headline: Should You Investigate IDEXX Laboratories, Inc. (NASDAQ:IDXX) At US$488?, source:Yahoo, summary: Today we're going to take a look at the well-established IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's stock..., Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.38% to $486.16 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
107,2023-03-07,"Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 2.50% to $473.99 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P...",IDXX
108,2023-03-08,"Headline: Why Is Idexx (IDXX) Down 6.6% Since Last Earnings Report?, source:Yahoo, summary: Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: TMO or IDXX: Which Is the Better Value Stock Right Now?, source:Yahoo, summary: TMO vs. IDXX: Which Stock Is the Better Value Option?, Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.74% to $482.22 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with...",IDXX
109,2023-03-09,"Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 2.06% to $472.28 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
110,2023-03-10,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 3.69% to $454.86 Friday, on what proved to be an all-around rough trading session for the stock market, with the...",IDXX
111,2023-03-13,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.33% to $460.92 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
112,2023-03-14,"Headline: The total return for IDEXX Laboratories (NASDAQ:IDXX) investors has risen faster than earnings growth over the last five years, source:Yahoo, summary: The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, a..., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 2.28% to $471.42 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
113,2023-03-15,"Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 1.37% to $464.97 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",IDXX
114,2023-03-16,"Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.97% to $474.11 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",IDXX
115,2023-03-17,"Headline: IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.58% to $471.36 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
116,2023-03-18,"Headline: These 4 Measures Indicate That IDEXX Laboratories (NASDAQ:IDXX) Is Using Debt Reasonably Well, source:Yahoo, summary: The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...",IDXX
117,2023-03-20,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.52% to $483.26 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
118,2023-03-22,"Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 4.11% to $475.03 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
119,2023-03-23,"Headline: Idexx Laboratories price target raised to $590 from $543 at Morgan Stanley, source:Thefly.com, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.78% higher to $478.74 Thursday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
120,2023-03-24,"Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.41% to $485.51 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
121,2023-03-27,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.73% higher to $489.05 Monday, on what proved to be an all-around favorable trading session for the stock market,...",IDXX
122,2023-03-28,"Headline: IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.19% to $488.14 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
123,2023-03-29,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.11% to $487.62 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
124,2023-03-30,"Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.22% to $493.55 Thursday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
125,2023-03-31,"Headline: Strong Q3 Results Pushed IDEXX Laboratories (IDXX) in Q4, source:Yahoo, summary: TimesSquare Capital Management, an equity investment management company, released its “U.S. Mid Cap Growth Strategy” fourth-quarter investor letter. A copy of the same can be downloaded here. In the fourth quarter, the strategy returned 4.18% (net), compared to 6.90% for the Russell Midcap Growth Index. For the calendar year, the strategy returned -22.13% (net) compared to […], Headline: IDEXX Laboratories Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.32% to $500.08 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
126,2023-04-02,"Headline: Tracking Ron Baron`s BAMCO Portfolio - Q4 2022 Update, source:Seeking Alpha, summary: No summary, Headline: Tracking Ron Baron's BAMCO Portfolio - Q4 2022 Update, source:SeekingAlpha, summary: BAMCOâs 13F portfolio value decreased from $30.95B to $29.78B this quarter. Click here to read more about Ron Baron's holdings and trades for Q4 2022.",IDXX
127,2023-04-03,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 2.16% to $489.27 Monday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
128,2023-04-04,"Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.08% to $484.01 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the...",IDXX
129,2023-04-05,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.51% to $476.69 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
130,2023-04-06,"Headline: What Is IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) Share Price Doing?, source:Yahoo, summary: IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) saw a double-digit share price rise of over 10% in the past couple of months..., Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. sank 0.87% to $472.52 Thursday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
131,2023-04-10,"Headline: Idexx Laboratories Moves Up In Market Cap Rank, Passing Paychex, source:The Online Investor, summary: No summary, Headline: Tracking Terry Smith`s Fundsmith 13F Portfolio - Q4 2022 Update, source:Seeking Alpha, summary: No summary, Headline: Tracking Terry Smith's Fundsmith 13F Portfolio - Q4 2022 Update, source:SeekingAlpha, summary: nan, Headline: Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now, source:Yahoo, summary: Investors are optimistic about IDEXX's (IDXX) strength in the Companion Animal Group business., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.99% higher to $477.22 Monday, on what proved to be an all-around great trading session for the stock market, with...",IDXX
132,2023-04-11,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.19% higher to $478.13 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with...",IDXX
133,2023-04-12,"Headline: China reports world`s first human death due to H3N8 bird flu ��� WHO, source:Seeking Alpha, summary: No summary, Headline: ALC vs. IDXX: Which Stock Is the Better Value Option?, source:Yahoo, summary: ALC vs. IDXX: Which Stock Is the Better Value Option?, Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.51% to $470.90 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with...",IDXX
134,2023-04-13,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.93% to $480.01 Thursday, on what proved to be an all-around favorable trading session for the stock market, with..., Headline: IDEXX Laboratories to Release 2023 First Quarter Financial Results, source:Yahoo, summary: WESTBROOK, Maine, April 13, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 first quarter results for Tuesday, May 2, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.",IDXX
135,2023-04-14,"Headline: Those who invested in IDEXX Laboratories (NASDAQ:IDXX) five years ago are up 143%, source:Yahoo, summary: The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put..., Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.52% higher to $482.49 Friday, on what proved to be an all-around dismal trading session for the stock market, with..., Headline: ClearBridge Mid Cap Strategy Q1 2023 Portfolio Manager Commentary, source:SeekingAlpha, summary: nan",IDXX
136,2023-04-17,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. dropped 0.20% to $481.52 Monday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
137,2023-04-18,"Headline: 3 Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio, source:Yahoo, summary: Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.12% higher to $482.12 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with...",IDXX
138,2023-04-19,"Headline: IDEXX Laboratories Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.16% to $487.70 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",IDXX
139,2023-04-20,"Headline: Masimo's (MASI) New FDA Approval to Improve Patient Monitoring, source:Yahoo, summary: Masimo's (MASI) receipt of the FDA's clearance for the Rad-G with Temperature is expected to support clinicians in almost any care scenario., Headline: Zimmer Biomet (ZBH) Hits 52-Week High: What's Driving It?, source:Yahoo, summary: Investors are optimistic about Zimmer Biomet's (ZBH) continued business recovery., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.60% higher to $490.61 Thursday, on what proved to be an all-around poor trading session for the stock market, with...",IDXX
140,2023-04-21,"Headline: IDEXX Laboratories (IDXX) to Post Q1 Earnings: What's in Store?, source:Yahoo, summary: IDEXX Laboratories' (IDXX) first-quarter 2023 results are expected to reflect an impressive performance in the CAG segment despite inflationary impacts., Headline: AmerisourceBergen's (ABC) New JV to Boost Oncology Care, source:Yahoo, summary: AmerisourceBergen's (ABC) new JV is expected to provide the independent community oncology network with additional resources and expertise to grow the platform and improve patient outcomes., Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.03% to $495.65 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
141,2023-04-22,"Headline: IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Quite Sensibly, source:Yahoo, summary: David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...",IDXX
142,2023-04-24,"Headline: 3 Pet Stocks That Could Purr in 2023 and Beyond, source:Yahoo, summary: Animal-loving investors may be interested in exploring opportunities in the pet industry. While there are altruistic reasons for supporting companies that focus on the well-being of our furry friends, pet stocks have also seen impressive growth over the past decade, which was accelerated by the pandemic. With everyone locked indoors, the pandemic really re-shaped how many people previously thought about pets. Therefore, this is a space that’s seen higher interest in post-pandemic years, despite",IDXX
143,2023-04-25,"Headline: Idexx Laboratories (IDXX) Earnings Expected to Grow: Should You Buy?, source:Yahoo, summary: Idexx (IDXX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: 7 ESG Stocks to Buy That Analysts Love, source:Yahoo, summary: Stereotypically, the concept of bidding up publicly traded enterprises based on their environmental, social, and governance scores – the so-called ESG stocks – might seem an extremely risky proposition. That’s because we have this idea that doing good involves sacrificing capitalistic intent like achieving profitability. To some extent, it’s a reasonable assumption. After all, true charity doesn’t involve a cynical attempt to move up financially. However, some evidence indicates that ESG stocks, Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 4.05% to $483.23 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
144,2023-04-26,"Headline: IDEXX Laboratories Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.37% to $481.44 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the...",IDXX
145,2023-04-27,"Headline: Will Alphatec (ATEC) Report Negative Earnings Next Week? What You Should Know, source:Yahoo, summary: Alphatec (ATEC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations., Headline: 3 Stocks to Buy to Benefit from the Booming Pet Care Industry, source:Yahoo, summary: The pandemic changed a lot of types of consumer behavior, and one of the most prevalent areas was the pet industry. People seeking more companionship during quarantine had a favorable impact on pet stocks, with several seeing their share prices soar to unprecedented heights. Since then some pet stocks have cooled back off and newer data has cast some doubts on the actual extent of the purported rise in pet adoptions in recent years. By the Fall of 2022, it appears pet adoption levels have return",IDXX
146,2023-04-28,"Headline: Baron Partners Fund Q4 2022 Quarterly Letter, source:Seeking Alpha, summary: No summary, Headline: Why These 2 Vet Med Stocks Are Surging, source:Yahoo, summary: Over the past decade, spending on veterinary care has tripled in the United States.  The growth in that spending makes veterinary care stocks somewhat recession proof.  More and more, spending on pet healthcare is seen as something people need rather than want., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.56% to $492.16 Friday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
147,2023-05-01,"Headline: Notable earnings before Tuesday`s open, source:Seeking Alpha, summary: No summary, Headline: IDEXX Laboratories Q1 2023 Earnings Preview, source:Seeking Alpha, summary: No summary, Headline: IDEXX Laboratories Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slumped 0.52% to $489.60 Monday, on what proved to be an all-around dismal trading session for the stock market, with the..., Headline: GLOBAL BRIEFING: HSBC Q1 pretax profit surges to nearly USD13 billion, source:Alliance News, summary: No summary",IDXX
148,2023-05-02,"Headline: IDEXX Laboratories GAAP EPS of $2.55 beats by $0.17, revenue of $900M beats by $9.4M, source:Seeking Alpha, summary: No summary, Headline: Idexx Laboratories reports Q1 EPS $2.55, consensus $2.42, source:Thefly.com, summary: No summary, Headline: Idexx Laboratories narrows 2023 EPS view to $9.33-$9.75 from $9.27-$9.75, source:Thefly.com, summary: No summary, Headline: IDEXX Laboratories beats Q1 estimates on top and bottom line, increases outlook, source:Seeking Alpha, summary: No summary, Headline: Do You Believe in the Long-Term Growth Prospects of IDEXX Laboratories (IDXX)?, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Asset Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here. The fund appreciated 5.34% in the first quarter, trailing the Russell Midcap Growth Index, which returned 9.14%. Stock selection drove the fund to underperform in the quarter. IT, Communication Services, and […], Headline: Idexx: Q1 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: IDEXX 1Q Net Up on Strong Veterinary Software Sales, source:MarketWatch, summary: By Rob Curran IDEXX Laboratories said its first-quarter net income rose 10% on growing demand for its veterinary software. For the quarter ended March 31,..., Headline: IDEXX Labs Boosts 2023 Revenue Projection Due to Strong Demand, source:MarketWatch, summary: By Rob Curran IDEXX Laboratories Inc. boosted its revenue growth projection and lifted its earnings forecast's lower-end for the year 2023, amid strong..., Headline: Idexx hails strong execution of strategy as revenue rises in quarter, source:Alliance News, summary: No summary, Headline: Ecolab 1Q Net Up on Rising Demand, source:MarketWatch, summary: By Rob Curran Ecolab said first-quarter earnings rose 36% as demand for laboratory services heated up, offsetting the impact of inflation. The St. Paul,..., Headline: Idexx Laboratories (IDXX) Gets a Buy from Goldman Sachs, source:TipRanks, summary: No summary, Headline: IDEXX Laboratories Announces First Quarter Results, source:Yahoo, summary: WESTBROOK, Maine, May 02, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced first quarter results., Headline: Idexx Laboratories (IDXX) Q1 Earnings and Revenues Beat Estimates, source:Yahoo, summary: Idexx (IDXX) delivered earnings and revenue surprises of 7.14% and 1.45%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?, Headline: IDEXX Laboratories, Inc. (IDXX) Q1 2023 Earnings Call Transcript, source:SeekingAlpha, summary: IDEXX Laboratories, Inc. (NASDAQ:NASDAQ:IDXX) Q1 2023 Earnings Conference Call May 2, 2023 8:30 AM ETCompany ParticipantsJay Mazelsky - President and Chief Executive OfficerBrian McKeon -..., Headline: Compared to Estimates, Idexx (IDXX) Q1 Earnings: A Look at Key Metrics, source:Yahoo, summary: The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended March 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals., Headline: IDEXX (IDXX) Q1 Earnings Beat Estimates, Margins Increase, source:Yahoo, summary: Continued solid demand for veterinary services and record global premium instrument placements drive IDEXX's (IDXX) Q1 revenues., Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 4.54% to $467.38 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P..., Headline: Health Care Down Slightly After Pfizer Earnings -- Health Care Roundup, source:MarketWatch, summary: Health-care companies fell, but not by as much as the broad market, after a generally strong round of earnings reports. Pfizer shares fell slightly after the..., Headline: Q1 2023 IDEXX Laboratories Inc Earnings Call, source:Yahoo, summary: Q1 2023 IDEXX Laboratories Inc Earnings Call",IDXX
149,2023-05-03,"Headline: Wall Street Analysts Are Bullish on Top Healthcare Picks, source:TipRanks, summary: No summary, Headline: Atlantic Equities Reiterates Idexx Laboratories (IDXX) Overweight Recommendation, source:Fintel, summary: nan, Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 2.45% to $478.83 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the...",IDXX
150,2023-05-04,"Headline: Baron Asset Fund Q1 2023 Quarterly Letter, source:SeekingAlpha, summary: Stocks rose on investorsâ hopes that moderating inflation and certain weakening economic indicators might lead the Federal Reserve to end its cycle of interest rate increases., Headline: Baron Health Care Fund Q1 2023 Shareholder Letter, source:SeekingAlpha, summary: Baron is an asset management firm focused on delivering growth equity investment solutions known for a long-term, fundamental, active approach to growth investing., Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.95% to $469.51 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
151,2023-05-05,"Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: No summary, Headline: Morgan Stanley Sticks to Its Buy Rating for Idexx Laboratories (IDXX), source:TipRanks, summary: No summary",IDXX
152,2023-05-06,"Headline: IDEXX Laboratories Q1 Earnings: Strong Results But Hard To Justify The Price, source:Seeking Alpha, summary: No summary, Headline: At US$488, Is It Time To Put IDEXX Laboratories, Inc. (NASDAQ:IDXX) On Your Watch List?, source:Yahoo, summary: Let's talk about the popular IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's shares received a lot of attention...",IDXX
153,2023-05-08,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.61% to $485.53 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",IDXX
154,2023-05-09,"Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.27% to $479.37 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...",IDXX
155,2023-05-10,"Headline: 3 Best Stocks to Buy in May and Hold Forever, source:Yahoo, summary: In need of healthcare exposure in your portfolio? Consider holding these three promising companies forever., Headline: IDEXX Laboratories to Present at Stifel Conference and Announces 2023 Investor Day, source:Yahoo, summary: WESTBROOK, Maine, May 10, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, 2023. Jay Mazelsky, President and Chief Executive Officer, and Brian McKeon, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at 1:15 pm (EDT)., Headline: IDEXX Laboratories Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.20% to $485.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the..., Headline: Ron Baron`s Baron Partners Fund 1st-Quarter Letter, source:GuruFocus, summary: No summary",IDXX
156,2023-05-12,"Headline: IDEXX Laboratories Could Beat FY23 Guidance, But Valuation Is An Issue, source:SeekingAlpha, summary: IDEXX reported positive 1Q23 results, with consistent organic growth in the US and an accelerated growth rate in international CAG Dx. Read more about IDXX here., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.15% higher to $487.47 Friday, on what proved to be an all-around grim trading session for the stock market, with...",IDXX
157,2023-05-15,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.49% higher to $489.88 Monday, on what proved to be an all-around favorable trading session for the stock market,...",IDXX
158,2023-05-16,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.42% higher to $491.93 Tuesday, on what proved to be an all-around poor trading session for the stock market, with...",IDXX
159,2023-05-17,"Headline: Investing in IDEXX Laboratories (NASDAQ:IDXX) five years ago would have delivered you a 146% gain, source:Yahoo, summary: When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose..., Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. sank 0.98% to $487.12 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
160,2023-05-18,"Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.01% to $492.06 Thursday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
161,2023-05-19,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slumped 0.80% to $488.10 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P...",IDXX
162,2023-05-22,"Headline: IDEXX Laboratories (NASDAQ:IDXX) Has A Pretty Healthy Balance Sheet, source:Yahoo, summary: Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility..., Headline: IDEXX Laboratories Inc. stock falls Monday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.38% to $486.25 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",IDXX
163,2023-05-23,"Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
164,2023-05-24,"Headline: IDEXX Laboratories Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: No summary",IDXX
165,2023-05-25,"Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: No summary",IDXX
166,2023-05-26,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 2.38% to $468.94 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
167,2023-05-29,"Headline: Here’s Why IDEXX Laboratories (IDXX) Rose in Q1, source:Yahoo, summary: Conestoga Capital Advisors, an asset management company, released its “Mid Cap Strategy” first-quarter 2023 investor letter. A copy of the same can be downloaded here. The Mid Cap Composite rose 10.23% net of fees in the first quarter, compared to the Russell Midcap Growth Index’s 9.14% return. The strategy primarily benefitted from the stock selection while the […]",IDXX
168,2023-05-30,"Headline: Tracking Terry Smith's Fundsmith 13F Portfolio - Q1 2023 Update, source:SeekingAlpha, summary: Fundsmith's 13F portfolio value increased by 6% to $23.17B in Q1 2023. Read more to see the portfolio's full Q1 2023 update., Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. dropped 0.58% to $466.22 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
169,2023-05-31,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.31% to $464.77 Wednesday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
170,2023-06-01,"Headline: Idexx (IDXX) Down 2.9% Since Last Earnings Report: Can It Rebound?, source:Yahoo, summary: Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.09% to $469.84 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",IDXX
171,2023-06-02,"Headline: IDEXX Laboratories Inc. stock rises Friday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.21% higher to $470.83 Friday, on what proved to be an all-around favorable trading session for the stock market,...",IDXX
172,2023-06-05,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.18% to $465.28 Monday, on what proved to be an all-around rough trading session for the stock market, with the...",IDXX
173,2023-06-06,"Headline: $1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth This Much Today, source:Benzinga, summary: No summary, Headline: Here's Why You Should Invest in IDEXX (IDXX) Right Now, source:Yahoo, summary: Investors continue to be optimistic about IDEXX (IDXX) on the strength of the Companion Animal Group business., Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 1.24% to $459.53 Tuesday, on what proved to be an all-around positive trading session for the stock market, with..., Headline: Lightning Round: If you have to buy Chinese stock buy Alibaba, says Jim Cramer, source:CNBC, summary: 'Mad Money' host Jim Cramer weighs in on stocks including: Equitrans, IDEXX Labs, Alibaba, Snap-On, Jabil, Getty, Shockwave and General Electric.",IDXX
174,2023-06-07,"Headline: Wall Street Analysts Are Bullish on Top Healthcare Picks, source:TipRanks, summary: No summary, Headline: Is Now The Time To Look At Buying IDEXX Laboratories, Inc. (NASDAQ:IDXX)?, source:Yahoo, summary: Let's talk about the popular IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's shares received a lot of attention..., Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.92% to $450.70 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the..., Headline: Atlantic Equities Reiterates Idexx Laboratories (IDXX) Prior Recommendation, source:Fintel, summary: nan",IDXX
175,2023-06-08,"Headline: 3 Nasdaq Stocks That Have Generated 10x Returns in 10 Years, source:Yahoo, summary: The Nasdaq is home to many of the best growth stocks in the world. Some of them have generated life-changing returns for investors, including Apple (NASDAQ: AAPL), Nvidia (NASDAQ: NVDA), and Idexx Laboratories (NASDAQ: IDXX)., Headline: IDEXX Laboratories Inc. stock rises Thursday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.51% higher to $453.00 Thursday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
176,2023-06-09,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.47% to $450.87 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
177,2023-06-12,"Headline: IDEXX Laboratories Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 2.13% to $460.48 Monday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
178,2023-06-13,"Headline: IDEXX Laboratories Inc. stock rises Tuesday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.74% to $468.47 Tuesday, on what proved to be an all-around positive trading session for the stock market, with...",IDXX
179,2023-06-14,"Headline: IDEXX Laboratories Inc. stock falls Wednesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.32% to $466.97 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
180,2023-06-15,"Headline: IDEXX Announces Novel Diagnostic Test for Kidney Injury, Expanding the Veterinary Industry's Most Comprehensive Renal Testing Portfolio, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of the first veterinary diagnostic test for detecting kidney injury in cats and dogs. According to a recent IDEXX survey, as many as one-third of kidney cases seen by veterinarians are related to kidney injury, and a diagnosis can be challenging due to subtle or nonspecific signs.1 The IDEXX Cystatin B Test will be included in test panels assessing renal health, uncovering new clinic, Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 3.09% to $481.42 Thursday, on what proved to be an all-around favorable trading session for the stock market, with..., Headline: Tracking Ron Baron's BAMCO Portfolio - Q1 2023 Update, source:SeekingAlpha, summary: Ron Baron's 13F portfolio value increased from $29.78B to $33.31B in Q1 2023. Explore here for the recent stake increases and top holdings in the portfolio.",IDXX
181,2023-06-16,"Headline: IDEXX (IDXX) Launches First Veterinary Diagnostic Test, source:Yahoo, summary: IDEXX's (IDXX) Cystatin B Test can help veterinary professionals to spot kidney damage before it affects kidney function, which may result in better patient outcomes., Headline: IDEXX Laboratories (NASDAQ:IDXX) jumps 6.3% this week, though earnings growth is still tracking behind five-year shareholder returns, source:Yahoo, summary: When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose..., Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.33% higher to $483.03 Friday, on what proved to be an all-around rough trading session for the stock market, with...",IDXX
182,2023-06-18,"Headline: IDEXX: One Of The Best But Too Expensive To Risk It, source:SeekingAlpha, summary: IDEXX Laboratories is a global company that provides products and services for primarily companion animals. Read why I think IDXX stock is very expensive.",IDXX
183,2023-06-19,"Headline: IDEXX (IDXX) Stock Up 18.4% YTD: Will the Rally Continue?, source:Yahoo, summary: The continued solid demand for veterinary services and benefits from strong execution poise IDEXX (IDXX) well for future growth.",IDXX
184,2023-06-21,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.75% higher to $485.82 Wednesday, on what proved to be an all-around rough trading session for the stock market,...",IDXX
185,2023-06-22,"Headline: $1000 Invested In IDEXX Laboratories 5 Years Ago Would Be Worth This Much Today, source:Benzinga, summary: No summary, Headline: IDEXX Laboratories Inc. stock rises Thursday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.01% to $490.72 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P...",IDXX
186,2023-06-23,"Headline: VNRX: Highlights of Capital Markets Day (Nu.Q NETs & Nu.Q Vet); Heska being acquired by Mars (increases Nu.Q Vet distribution footprint); 13 MM share offering completed, source:Yahoo, summary: By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Highlights of Annual Capital Markets Day On May 11, 2023, VolitionRx (NYSE:VNRX) conducted the company’s Annual Capital Markets Day. The presentations included the current status and prospects of Nu.Q NETs and Nu.Q Vet , the two pillars of the company that are entering the commercialization phase. Volition’s blood tests (assays), Headline: Ron Baron Expects Growth to Accelerate Above 7% Over Next 50 Years, source:GuruFocus, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. sank 0.60% to $487.78 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P...",IDXX
187,2023-06-26,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.22% to $481.82 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
188,2023-06-27,"Headline: IDEXX Laboratories Inc. stock rises Tuesday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.49% higher to $484.20 Tuesday, on what proved to be an all-around great trading session for the stock market, with...",IDXX
189,2023-06-28,"Headline: A Look Into IDEXX Laboratories' Debt, source:Benzinga, summary: No summary",IDXX
190,2023-06-29,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.64% higher to $494.49 Thursday, on what proved to be an all-around positive trading session for the stock market,..., Headline: IDEXX: One Of The Best Compounders On The Market, source:SeekingAlpha, summary: IDEXX benefits from strong secular growth and its ability to turn high growth into rapidly rising free cash flow used to buy back stock. Read more about IDXX., Headline: IDEXX Laboratories to Release 2023 Second Quarter Financial Results, source:Yahoo, summary: WESTBROOK, Maine, June 29, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2023 second quarter results for Tuesday, August 1, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.",IDXX
191,2023-06-30,"Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 1.57% to $502.23 Friday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
192,2023-07-03,"Headline: (IDXX) - Analyzing IDEXX Laboratories's Short Interest, source:Benzinga, summary: No summary",IDXX
193,2023-07-05,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.47% higher to $492.46 Wednesday, on what proved to be an all-around grim trading session for the stock market,...",IDXX
194,2023-07-06,"Headline: IDEXX Laboratories Inc. stock outperforms market despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.25% to $491.23 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
195,2023-07-07,"Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.38% to $498.01 Friday, on what proved to be an all-around dismal trading session for the stock market, with the...",IDXX
196,2023-07-09,"Headline: When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?, source:Yahoo, summary: Today we're going to take a look at the well-established IDEXX Laboratories, Inc. ( NASDAQ:IDXX ). The company's stock...",IDXX
197,2023-07-10,"Headline: IDEXX Laboratories Inc. stock rises Monday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 4.66% to $521.21 Monday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
198,2023-07-11,"Headline: Fundsmith Equity Fund H1 2023 Letter To Shareholders, source:SeekingAlpha, summary: Fundsmith Equity Fund was up by 8.5% in H1 2023, marginally less than the MSCI World Index. What did well for us? Click here to read the full fund letter., Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.23% to $514.82 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the...",IDXX
199,2023-07-12,"Headline: Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 20 Years, source:Benzinga, summary: No summary, Headline: IDEXX Laboratories Elects Irene Chang Britt to Board of Directors, source:Yahoo, summary: WESTBROOK, Maine, July 12, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the election of Irene Chang Britt, a former executive at Campbell Soup Company, to the Company's Board of Directors, effective July 11, 2023., Headline: IDEXX Laboratories Inc. stock rises Wednesday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 2.11% to $525.68 Wednesday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
200,2023-07-13,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.35% to $532.80 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the...",IDXX
201,2023-07-14,"Headline: Idexx Laboratories (IDXX) is a Top-Ranked Momentum Stock: Should You Buy?, source:Yahoo, summary: The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",IDXX
202,2023-07-16,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",IDXX
203,2023-07-18,"Headline: IDEXX Laboratories Inc. stock falls Tuesday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. sank 0.79% to $547.47 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
204,2023-07-19,"Headline: Thermo Fisher Scientific Inc(TMO): A Comprehensive GF Score Analysis, source:GuruFocus, summary: No summary, Headline: IDEXX Laboratories' (NASDAQ:IDXX) 17% CAGR outpaced the company's earnings growth over the same five-year period, source:Yahoo, summary: The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company..., Headline: IDEXX Laboratories Inc. stock rises Wednesday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.05% higher to $547.75 Wednesday, on what proved to be an all-around great trading session for the stock market,..., Headline: Zoetis: The Animal Drug Monarch In The Era Of Soaring Companion Animal Demand, source:SeekingAlpha, summary: Zoetis has seen significant growth since its spin-off from Pfizer, particularly in the companion animal sector. Read more to see my analysis on ZTS stock., Headline: First Watch Announces Appointment of Irene Chang Britt to Board of Directors, source:Yahoo, summary: Leading Daytime Dining concept strengthens Board amid continued execution of accelerated growth strategy Irene Chang Britt Irene Chang Britt has served as a director since July 2023. BRADENTON, Fla., July 19, 2023 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the appointment of Irene Chang Britt to its Board of Directors, effective immediately. Ms. Cha, Headline: Peering Into IDEXX Laboratories's Recent Short Interest, source:Benzinga, summary: No summary",IDXX
205,2023-07-20,"Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 0.89% to $542.86 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow...",IDXX
206,2023-07-21,"Headline: GF Score Analysis: Thermo Fisher Scientific Inc (TMO), source:GuruFocus, summary: No summary, Headline: IDEXX: Best In Class Growth And Recession-Resistant With Hefty Valuation, source:SeekingAlpha, summary: IDEXX Laboratories is targeting 10%+ organic sales growth and 15-20% EPS growth, making it a high-quality, recession-resistant company. Click here to read more., Headline: IDEXX Laboratories (IDXX) to Post Q2 Earnings: What's in Store?, source:Yahoo, summary: IDEXX Laboratories' (IDXX) second-quarter 2023 results are expected to reflect an impressive performance in the CAG segment., Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 2.16% to $554.60 Friday, on what proved to be an all-around favorable trading session for the stock market, with...",IDXX
207,2023-07-24,"Headline: IDEXX Laboratories Inc. stock underperforms Monday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slid 0.10% to $554.03 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
208,2023-07-25,"Headline: IDEXX Releases 2022 Corporate Responsibility Report, Providing Environmental, Social, and Governance Updates, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today published its 2022 Corporate Responsibility Report, highlighting progress against the environmental, social, and governance (ESG) goals it announced last year. The report also introduces a framework to focus and prioritize the company's ESG goals and initiatives. The framework includes three pillars focused on the environmental and social priorities most important to IDEXX's stakeholders and business, un, Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.48% higher to $556.67 Tuesday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
209,2023-07-26,"Headline: IDEXX Releases 2022 Corporate Responsibility Report, source:Finnhub, summary: WESTBROOK, Maine - IDEXX Laboratories, Inc. , a global leader in pet healthcare innovation, today published its 2022 Corporate Responsibility Report, highlighting progress against the environmental,..., Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. sank 0.09% to $556.16 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the...",IDXX
210,2023-07-27,"Headline: Is IDEXX Laboratories (NASDAQ:IDXX) Using Too Much Debt?, source:Yahoo, summary: Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of..., Headline: IDEXX Laboratories Inc. stock falls Thursday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 1.83% to $545.96 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the..., Headline: Cramer's Lightning Round: Topgolf Callaway Brands is a buy, source:CNBC, summary: ""Mad Money"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed., Headline: Lightning Round: Cramer on Callaway, IDEXX, Teledoc and Lucid, source:CNBC, summary: 'Mad Money' host Jim Cramer weighs in on stocks including: Topgolf, Idexx Lab, Teladoc Health, Lucid, Johnson Controls and JD.com., Headline: $1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today, source:Benzinga, summary: No summary",IDXX
211,2023-07-28,"Headline: Jim Cramer Says This E-Commerce Giant 'Is One Of The Only Ones' That 'Has Really Got The Momentum In China', source:Benzinga, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.25% to $552.78 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P...",IDXX
212,2023-07-30,"Headline: Baron Small Cap Fund Q2 2023 Shareholder Letter, source:SeekingAlpha, summary: Baron Small Cap FundÂ® was up 6.49% (Institutional Shares) in the Q2 2023 and was up 16.54% for the first half of the year. Click here to read the full fund letter., Headline: Analysts Are Bullish on Top Healthcare Stocks: Eli Lilly & Co (LLY), Idexx Laboratories (IDXX), source:TipRanks, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: No summary",IDXX
213,2023-07-31,"Headline: Notable earnings before Tuesday's open, source:Seeking Alpha, summary: No summary, Headline: IDEXX Laboratories Q2 2023 Earnings Preview, source:Seeking Alpha, summary: No summary, Headline: GLOBAL BRIEFING: Australian central bank pauses rates; HSBC profit up, source:Alliance News, summary: No summary, Headline: IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
214,2023-08-01,"Headline: IDEXX Laboratories' Q2 Earnings Top Estimates, Analyst Maintain Outperform Citing Resilient Animal Health Market, source:Benzinga, summary: No summary, Headline: IDEXX Laboratories Non-GAAP EPS of $2.70 beats by $0.23, revenue of $943.63M beats by $9.58M, source:Seeking Alpha, summary: No summary, Headline: Idexx Laboratories reports Q2 EPS $2.67, consensus $2.47, source:Thefly.com, summary: No summary, Headline: Idexx Laboratories raises FY23 EPS view to $9.64-$9.90 from $9.33-$9.75, source:Thefly.com, summary: No summary, Headline: Idexx: Q2 Earnings Snapshot, source:Associated Press, The, summary: No summary, Headline: Idexx : Q2 Earnings Snapshot, source:Finnhub, summary: WESTBROOK, Maine  — WESTBROOK, Maine  — Idexx Laboratories Inc.  on Tuesday reported second-quarter earnings of $224.2 million.
  On a per-share basis, the Westbrook, Maine-based company said..., Headline: Idexx Laboratories (IDXX) Receives a Buy from Goldman Sachs, source:TipRanks, summary: No summary, Headline: IDEXX Laboratories second quarter figures rise; expects growth, source:Alliance News, summary: No summary, Headline: IDEXX Laboratories Announces Second Quarter Results, source:Yahoo, summary: WESTBROOK, Maine, August 01, 2023--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results., Headline: Idexx Laboratories (IDXX) Q2 Earnings and Revenues Beat Estimates, source:Yahoo, summary: Idexx (IDXX) delivered earnings and revenue surprises of 9.88% and 1.70%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?, Headline: IDEXX Labs lifts annual forecasts as pet owners return to vet clinics, source:Reuters, summary: IDEXX Laboratories raised its full-year profit and sales forecasts on Tuesday, betting on higher demand for its diagnostic tests and lab services as more pet owners visit veterinary clinics., Headline: IDEXX Laboratories, Inc. (IDXX) Q2 2023 Earnings Call Transcript, source:SeekingAlpha, summary: IDEXX Laboratories, Inc. (NASDAQ:NASDAQ:IDXX) Q2 2023 Earnings Conference Call August 1, 2023 8:30 AM ETCompany ParticipantsJay Mazelsky - President and Chief Executive OfficerBrian McKeon..., Headline: IDEXX (IDXX) Q2 Earnings and Revenues Beat Estimates, View Up, source:Yahoo, summary: IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth., Headline: Idexx (IDXX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates, source:Yahoo, summary: The headline numbers for Idexx (IDXX) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals., Headline: Q2 2023 IDEXX Laboratories Inc Earnings Call, source:Yahoo, summary: Q2 2023 IDEXX Laboratories Inc Earnings Call, Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
215,2023-08-02,"Headline: Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Vertex Pharmaceuticals (VRTX) and IQVIA Holdings (IQV), source:TipRanks, summary: No summary, Headline: Idexx Laboratories downgraded to Neutral from Overweight at Atlantic Equities, source:Thefly.com, summary: No summary, Headline: Idexx Laboratories (IDXX) Gets a Hold from Bank of America Securities, source:TipRanks, summary: No summary, Headline: Idexx Laboratories (IDXX) Receives a Hold from Stifel Nicolaus, source:TipRanks, summary: No summary, Headline: Atlantic Equities Downgrades Idexx Laboratories (IDXX), source:Fintel, summary: nan, Headline: IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2023 Earnings Call Transcript, source:Yahoo, summary: IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q2 2023 Earnings Call Transcript August 1, 2023 IDEXX Laboratories, Inc. misses on earnings expectations. Reported EPS is $1.56 EPS, expectations were $2.47. Operator: Good morning, and welcome to the IDEXX Laboratories Second Quarter 2023 Earnings Conference Call. As a reminder, today’s conference is being recorded. Participating in the call this […], Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
216,2023-08-03,"Headline: Thursday’s Top Analyst Upgrades and Downgrades: AMD, Caesars, Caterpillar, CrowdStrike, Electronic Arts, Estee Lauder, KeyCorp, Match, Sirius XM, SoFi and More, source:247WallSt, summary: No summary, Headline: Are Strong Financial Prospects The Force That Is Driving The Momentum In IDEXX Laboratories, Inc.'s NASDAQ:IDXX) Stock?, source:Yahoo, summary: IDEXX Laboratories' (NASDAQ:IDXX) stock is up by a considerable 11% over the past three months. Since the market..., Headline: Morgan Stanley Maintains Idexx Laboratories (IDXX) Overweight Recommendation, source:Fintel, summary: nan, Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: No summary",IDXX
217,2023-08-05,"Headline: 3 Top Healthcare Stocks to Buy for August, source:Yahoo, summary: Shares of Humana, Vertex Pharmaceuticals, and Idexx Laboratories have all increased by at least 20% so far this year.",IDXX
218,2023-08-06,"Headline: IDEXX Laboratories Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: No summary",IDXX
219,2023-08-07,"Headline: Analysts Offer Insights on Healthcare Companies: American Well (AMWL) and Idexx Laboratories (IDXX), source:TipRanks, summary: No summary",IDXX
220,2023-08-08,"Headline: Here's Why We Think IDEXX Laboratories (NASDAQ:IDXX) Is Well Worth Watching, source:Yahoo, summary: The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even..., Headline: Peering Into IDEXX Laboratories's Recent Short Interest, source:Benzinga, summary: No summary, Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",IDXX
221,2023-08-09,"Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
222,2023-08-10,"Headline: Goldman Sachs Remains a Buy on Idexx Laboratories (IDXX), source:TipRanks, summary: No summary, Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: No summary",IDXX
223,2023-08-11,"Headline: Analysts Offer Insights on Healthcare Companies: Structure Therapeutics, Inc. Sponsored ADR (GPCR), Avita Medical (RCEL) and Idexx Laboratories (IDXX), source:TipRanks, summary: No summary",IDXX
224,2023-08-13,"Headline: When Should You Buy IDEXX Laboratories, Inc. (NASDAQ:IDXX)?, source:Yahoo, summary: IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) saw a decent share price growth in the teens level on the NASDAQGS over the..., Headline: Analysts’ Opinions Are Mixed on These Healthcare Stocks: Insmed (INSM), Liquidia Technologies (LQDA) and Idexx Laboratories (IDXX), source:TipRanks, summary: No summary, Headline: IDEXX Laboratories Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: No summary",IDXX
225,2023-08-14,"Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: No summary",IDXX
226,2023-08-15,"Headline: IDEXX Laboratories Inc. stock underperforms Wednesday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
227,2023-08-16,"Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: No summary",IDXX
228,2023-08-17,"Headline: IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: No summary",IDXX
229,2023-08-18,"Headline: IDEXX Laboratories (NASDAQ:IDXX) sheds 4.2% this week, as yearly returns fall more in line with earnings growth, source:Yahoo, summary: It might be of some concern to shareholders to see the IDEXX Laboratories, Inc. ( NASDAQ:IDXX ) share price down 11% in..., Headline: Here's Why You Should Invest in IDEXX (IDXX) Stock Right Now, source:Yahoo, summary: Investors continue to be optimistic about IDEXX (IDXX) due to the CAG business and the company's execution of its growth strategy.",IDXX
230,2023-08-20,"Headline: IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: No summary",IDXX
231,2023-08-22,"Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. advanced 1.32% to $488.35 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the...",IDXX
232,2023-08-23,"Headline: 15 Highest Paying Countries for Veterinarians, source:Yahoo, summary: In this article, we will look at the 15 highest paying countries for veterinarians. We have also discussed challenges that veterinarians face and the companies that continue to contribute to the well-being of animals. If you want to skip our detailed analysis, head straight to the 5 Highest Paying Countries for Veterinarians. While veterinarians are […], Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 3.01% to $503.03 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
233,2023-08-24,"Headline: How Is The Market Feeling About IDEXX Laboratories?, source:Benzinga, summary: No summary, Headline: IDEXX Laboratories Inc. stock underperforms Thursday when compared to competitors, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. shed 3.38% to $486.02 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P...",IDXX
234,2023-08-25,"Headline: VolitionRx (VNRX): Review of 2Q 2023; Distribution Footprint of Nu.Q Vet Cancer Test is expanding. Prolific Schedule of Clinical Papers & Posters., source:Yahoo, summary: By Steven Ralston, CFA NYSE:VNRX READ THE FULL VNRX RESEARCH REPORT Second Quarter Highlights Nu.Q Vet Product sales of the Nu. Q Vet Canine Cancer Screening Test grew 459% YOY and 15.0% sequentially (off a low base) driven primarily by sales of reference kits through IDEXX, which launched the test in the U.S. during January. Domestically, IDEXX has 20 affiliated reference laboratories in which, Headline: IDEXX Laboratories Inc. stock rises Friday, outperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rose 1.37% to $492.68 Friday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
235,2023-08-27,"Headline: IDEXX Laboratories (NASDAQ:IDXX) Seems To Use Debt Rather Sparingly, source:Yahoo, summary: David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the..., Headline: 15 Most Undervalued Large Cap Stocks to Buy According to Wall Street Analysts, source:Yahoo, summary: In this piece, we will take a look at the 15 most undervalued large cap stocks to buy according to Wall Street analysts. If you want to skip our analysis of the latest in the stock market, then take a look at 5 Most Undervalued Large Cap Stocks to Buy. With the second half of […], Headline: Tracking Terry Smith's Fundsmith 13F Portfolio - Q2 2023 Update, source:SeekingAlpha, summary: Fundsmith's 13F portfolio value increased by approximately 3% this quarter, reaching $23.83B. Check out the holdings and trades for Q2 2023.",IDXX
236,2023-08-28,"Headline: IDEXX Laboratories Inc. stock rises Monday, still underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.08% higher to $493.08 Monday, on what proved to be an all-around positive trading session for the stock market,...",IDXX
237,2023-08-29,"Headline: Unveiling IDEXX Laboratories (IDXX)'s Value: Is It Really Priced Right? A Comprehensive Guide, source:Yahoo, summary: Delving into the intrinsic value of IDEXX Laboratories (IDXX) based on our exclusive GF Value methodology, Headline: Unpacking the Financial Strength and Growth Potential of IDEXX Laboratories Inc (IDXX), source:Yahoo, summary: Insights into the robust financial metrics and competitive advantages driving market outperformance, Headline: IDEXX Laboratories Inc. stock outperforms competitors on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. rallied 3.73% to $511.49 Tuesday, on what proved to be an all-around great trading session for the stock market, with the...",IDXX
238,2023-08-30,"Headline: IDEXX Laboratories Inc. stock outperforms competitors despite losses on the day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 0.13% to $510.81 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with..., Headline: Here's How Much $1000 Invested In IDEXX Laboratories 10 Years Ago Would Be Worth Today, source:Benzinga, summary: No summary",IDXX
239,2023-08-31,"Headline: 20 Most Dog Friendly Cities in the US, source:Yahoo, summary: In this article, we’ll take a look at the 20 Most Dog Friendly Cities in the US. You can skip our detailed analysis of the US pet industry, read the top 5 Most Dog Friendly Cities in the US. The four-legged companions aren’t just pets; they’re family. And like any family member, we want them to […], Headline: Here’s Why You Should Hold IDEXX Laboratories (IDXX) for the Long-Term, source:Yahoo, summary: Baron Funds, an investment management company, released its “Baron Small Cap Fund” second-quarter 2023 investor letter. A copy of the same can be downloaded here. The fund was 6.49% (Institutional Shares) up in the second quarter and 16.54% up for the first half of the year. This quarter, the Fund underperformed the broader S&P 500 Index, […], Headline: Idexx (IDXX) Down 1.6% Since Last Earnings Report: Can It Rebound?, source:Yahoo, summary: Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues., Headline: IDEXX Laboratories Inc. stock outperforms market on strong trading day, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. inched 0.12% higher to $511.41 Thursday, on what proved to be an all-around grim trading session for the stock market, with...",IDXX
240,2023-09-01,"Headline: IDEXX Laboratories Inc. stock falls Friday, underperforms market, source:MarketWatch, summary: Shares of IDEXX Laboratories Inc. slipped 0.02% to $511.29 Friday, on what proved to be an all-around positive trading session for the stock market, with the...",IDXX
